Host: Jerome Lisk, MD, MBA, M.S., FAAN <br>

  Guest: Peter Whitehouse, MD, PhD <br>


  
    <p>The FDA’s recent approval of aducanumab for the treatment of Alzheimer’s disease has been met with a controversial response. So what do we need to know about this new drug and its potential to treat this progressive neurological disorder? Dr. Jerome Lisk is joined by Dr. Peter Whitehouse from Case Western Reserve University to break down the approval of this new drug and what it could mean for patients. </p>

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Peter Whitehouse, MD, PhD The FDA’s recent approval of aducanumab for the treatment of Alzheimer’s disease has been met with a controversial response. So what do we need to know about this new drug and its potential to treat this progressive neurological disorder? Dr. Jerome Lisk is joined by Dr. Peter Whitehouse from Case Western Reserve University to break down the approval of this new drug and what it could mean for patients.

Diving into the Debate Surrounding Aducanumab for Alzheimer’s

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

Medicine

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health. So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

Share Diving into the Debate Surrounding Aducanumab for Alzheimer’s

Sign up to save your podcasts

Diving into the Debate Surrounding Aducanumab for Alzheimer’s

Diving into the Debate Surrounding Aducanumab for Alzheimer’s

More shows like NeuroFrontiers

This American Life

Radiolab

Neurology® Podcast

StoryCorps

The Daily

Neurology Today in 5

Neurology Minute

This Week in Neuroscience

Continuum Audio